Month: July 2021

DALLAS, July 19, 2021 (GLOBE NEWSWIRE) — DallasNews Corporation (Nasdaq: DALN) said today that it will release second quarter 2021 financial results before the market opens on Tuesday, July 27, 2021. A conference call will be held on Tuesday, July 27, 2021 at 9:00 a.m. CDT. The conference call will be simultaneously webcast on DallasNews Corporation’s website at investor.dallasnewscorporation.com/events. An archive of the webcast will be available at dallasnewscorporation.com in the Investor Relations section. To access the listen-only conference call, dial 1-844-291-6362 and enter the following access code when prompted: 8079115. A replay line will be available at 1-866-207-1041 from 12:00 p.m. CDT on July 27, 2021 until 11:59 p.m. CDT on August 2, 2021. The access code for the replay is 9670389. About DallasNews Corporation DallasNews...

ROSEMONT, Ill., July 19, 2021 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust”, “the Company”, “we” or “our”) (Nasdaq: WTFC) announced net income of $105.1 million or $1.70 per diluted common share for the second quarter of 2021, a decrease in diluted earnings per common share of 33% compared to the first quarter of 2021 and an increase of 400% compared to the second quarter of 2020. The Company recorded net income of $258.3 million or $4.24 per diluted common share for the first six months of 2021 compared to net income of $84.5 million or $1.38 per diluted common share for the same period of 2020. Highlights of the Second Quarter of 2021:Comparative information to the first quarter of 2021Total loans, excluding Paycheck Protection Program (“PPP”) loans,...

VANCOUVER, Washington, July 19, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Christopher Recknor, M.D., Chief Operating Officer and Head of Clinical Development, will host an investment community webcast on Thursday, July 22, 2021. Management will provide a full discussion of the results from the recently reported data from the mTNBC trials, along with updates on cancer, COVID-19, and NASH trials, and the status of the resubmission of the BLA for HIV. Management will provide approximately...

SAN CARLOS, Calif., July 19, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, will report its second quarter financial results on Thursday, August 5, 2021. Management will host a conference call and live audio webcast to discuss these results and provide a corporate update at 4:30 p.m. ET. To participate in the conference call, please dial 1-844-646-4465 (domestic) or 1-615-247-0257 (international) and reference the access code 1489438. The live webcast can be accessed in the Investors section of the Company’s website at www.iovance.com. The archived webcast will also be available for one year in the Investors section at www.iovance.com. About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics aims to improve patient...

SAN CARLOS Calif., July 19, 2021 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced the appointment of Dr. Stacey Ma, Executive Vice President and Head of Technical Operations at Sana Biotechnology, and Stephen R. Brady, Chief Executive Officer of Tempest Therapeutics, to its Board of Directors. “We are pleased to be expanding our Board of Directors with the addition of two experienced and accomplished biopharmaceutical executives” said John Orwin, Chief Executive Officer. “Together, Stacey and Steve bring over 40 years of industry experience across a variety of corporate functions, including research, technical...

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, July 19, 2021 (GLOBE NEWSWIRE) — The Flowr Corporation (“Flowr” or the “Company”) (TSXV: FLWR, OTC: FLWPF) is pleased to announce that today it has closed its previously announced private placement offering for 33,400,000 units (“Units”) of the Company at a price of $0.21 per Unit (the “Issue Price”) for gross proceeds of $7,014,000 (the “Offering”). ATB Capital Markets Inc. (“ATB”) acted as placement agent for the Offering pursuant to a placement agency agreement dated July 15, 2021 between the Company and ATB. Each Unit consists of one common share in the capital of the Company (a “Common Share”) and one Common Share purchase warrant (a “Warrant”)....

Figure 1Wasamac Strategic Production ProfileFigure 2Wasamac Mineral Reserves and Mineral Resources; Prospective Target Areas HighlightedFigure 3Wasamac Exploration Program Including Francoeur, Arntfield, and Lac FortuneFigure 4Quebec Gold Production ProfileFigure 5Quebec Gold Production Profile – UpsideTORONTO, July 19, 2021 (GLOBE NEWSWIRE) — YAMANA GOLD INC. (TSX: YRI; NYSE: AUY; LSE: AUY) (“Yamana” or “the Company”) is pleased to announce the results of several studies on the Company’s wholly-owned Wasamac project in the Abitibi-Témiscamingue Region of Quebec, Canada, intended to corroborate diligence reviews conducted by the Company on its purchase of the Wasamac project in early 2021 and update a historical feasibility study. These studies...

CINCINNATI, July 19, 2021 (GLOBE NEWSWIRE) — As previously announced by The Hillman Companies, Inc. (“Hillman” or the “Company”) on July 13, 2021, in anticipation of the merger contemplated by the Agreement and Plan of Merger, dated as of January 24, 2021, by and among Landcadia Holdings III, Inc. (“Landcadia”), Helios Sun Merger Sub, Inc. (“Merger Sub”), HMAN Group Holdings Inc. (“Hillman Holdco”) and CCMP Sellers’ Representative, LLC, solely in its capacity as representative of the stockholders of Hillman Holdco (the “Merger”), Hillman delivered a notice of redemption for all of its outstanding 11.6% Junior Subordianted Debentures due 2027 (the “Debentures”) on August 12, 2021 (the “Redemption Date”) and the Hillman Group Capital Trust delivered a notice of redemption for all of its issued and outstanding shares of Trust Preferred...